SCHEMBL4586665

SCHEMBL4586665

CS(=O)(=O)c1[c]ccc(-c2cc(Cl)ccc2S(N)(=O)=O)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 4/20 0.35
CA1 P00915 5/20 0.33
CA2 P00918 5/20 0.33
CCR2 P41597 2/20 0.33
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TRPV4 Q9HBA0 1/20 0.31
CA4 P22748 2/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
S100A4 P26447 1/20 0.31
CA3 P07451 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180903 0.81 CYP3A4 (0.35) PTGDR2PTGS2S100A4ALDH1A1POLB
SCHEMBL1967431 0.67 PTGS2 (0.32) PTGS2LMNA
SCHEMBL28076140 0.66 CCR2 (0.48) PTGES2CA1CA2CCR2ALDH1A1
SCHEMBL3313985 0.66
SCHEMBL7584026 0.65 PTGS2 (0.50) PTGES2CA1CA2CA12CA9
SCHEMBL28076150 0.64 PTGS2 (0.57) CA1CA2CCR2CA12CA9
SCHEMBL28076295 0.64 CCR2 (0.48) CCR2PTGS1PTGS2
SCHEMBL8296088 0.64 PDIA6 (0.51) PTGES2CA1CA2CA12CA9
SCHEMBL8295455 0.64 CDK1 (0.54) PTGES2CA1CA2CA12CA9
SCHEMBL10599899 0.64 CCR2 (0.49) CA1CA2CCR2TRPV4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603909-A4 LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-09-03 EP claimed
EP-1603909-A2 LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS Brystol-Myers Squibb Company (US) 2005-12-14 EP claimed
WO-2004083177-A2 LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS BRYSTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO claimed
EP-1603562-A4 SULFONYL-AMIDINO CONTAINING AND TETRAHYDROPYRIMIDINO CONTAINING COMPOUNDS AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-10-22 EP disclosed
EP-1603562-A2 SULFONYL-AMIDINO CONTAINING AND TETRAHYDROPYRIMIDINO CONTAINING COMPOUNDS AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-12-14 EP disclosed
WO-2004083174-A2 SULFONYL-AMIDINO CONTAINING AND TETRAHYDROPYRIMIDINO CONTAINING COMPOUNDS AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed